Literature DB >> 11168991

Role of nitric oxide in the synthesis of guanidinosuccinic acid, an activator of the N-methyl-D-aspartate receptor.

K Aoyagi1, S Shahrzad, S Iida, C Tomida, A Hirayama, S Nagase, K Takemura, A Koyama, S Ohba, M Narita, B D Cohen.   

Abstract

BACKGROUND: We propose that reactive oxygen and argininosuccinic acid (ASA) form guanidinosuccinic acid (GSA). An alternative to this hypothesis is the so-called guanidine cycle, which consists of a series of hydroxyurea derivatives that serve as intermediates in a pathway leading from urea to GSA. We compare the role of the guanidine cycle to that of nitric oxide (NO) in the synthesis of GSA.
METHODS: The members of the guanidine cycle (hydroxyurea, hydroxylamine plus homoserine, L-canaline, and L-canavanine) were incubated with isolated rat hepatocytes. The known NO donors, NOR-2, NOC-7, and SIN-1, were incubated with ASA in vitro. Ornithine, arginine, or citrulline, which increase arginine, a precursor of NO, were incubated with isolated rat hepatocytes. GSA was determined by high-performance liquid chromatography.
RESULTS: None of guanidine cycle members except for urea formed GSA. SIN-1, which generates superoxide and NO formed GSA, but other simple NO donors, did not. Both carboxy-PTIO, a scavenger of NO, and dimethyl sulfoxide, a hydroxyl radical scavenger, completely inhibited GSA synthesis by SIN-1. GSA formation by SIN-1 reached a maximum at 0.5 mmol/L and decreased at higher concentrations. GSA synthesis, stimulated by urea in isolated hepatocytes, was inhibited by ornithine, arginine, or citrulline with ammonia, but not by ornithine without ammonia, where arginine production is limited.
CONCLUSION: GSA is formed from ASA and the hydroxyl radical. When arginine increased in hepatocytes, GSA synthesis decreased. These data suggest that increased NO, which results from high concentrations of arginine, or SIN-1 scavenges the hydroxyl radical. This may explain the decreased GSA synthesis in inborn errors of the urea cycle where ASA is decreased, and also the diminished GSA excretion in arginemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168991     DOI: 10.1046/j.1523-1755.2001.59780093.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  11 in total

1.  Inhibition of arginine synthesis by urea: a mechanism for arginine deficiency in renal failure which leads to increased hydroxyl radical generation.

Authors:  Kazumasa Aoyagi
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

Review 2.  Methyl group deficiency and guanidino production in uremia.

Authors:  Burton D Cohen
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

Review 3.  Optimizing therapy for argininosuccinic aciduria.

Authors:  Sandesh C S Nagamani; Brendan Lee; Ayelet Erez
Journal:  Mol Genet Metab       Date:  2012-07-20       Impact factor: 4.797

Review 4.  Argininosuccinate lyase deficiency-argininosuccinic aciduria and beyond.

Authors:  Ayelet Erez; Sandesh C Sreenath Nagamani; Brendan Lee
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-02-10       Impact factor: 3.908

5.  Metabolomics analysis of the effects of quercetin on renal toxicity induced by cadmium exposure in rats.

Authors:  Tong Guan; Youwei Xin; Kai Zheng; Ruijuan Wang; Xia Zhang; Siqi Jia; Siqi Li; Can Cao; Xiujuan Zhao
Journal:  Biometals       Date:  2020-10-08       Impact factor: 2.949

6.  Premature aging in uremia.

Authors:  Burton D Cohen
Journal:  Mol Cell Biochem       Date:  2006-11-29       Impact factor: 3.842

7.  Metabolomics with LC-QTOF-MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolic fingerprint.

Authors:  Michal Ciborowski; Joanna Teul; Jose Luis Martin-Ventura; Jesús Egido; Coral Barbas
Journal:  PLoS One       Date:  2012-02-24       Impact factor: 3.240

8.  Expanding the phenotype in argininosuccinic aciduria: need for new therapies.

Authors:  Julien Baruteau; Elisabeth Jameson; Andrew A Morris; Anupam Chakrapani; Saikat Santra; Suresh Vijay; Huriye Kocadag; Clare E Beesley; Stephanie Grunewald; Elaine Murphy; Maureen Cleary; Helen Mundy; Lara Abulhoul; Alexander Broomfield; Robin Lachmann; Yusof Rahman; Peter H Robinson; Lesley MacPherson; Katharine Foster; W Kling Chong; Deborah A Ridout; Kirsten McKay Bounford; Simon N Waddington; Philippa B Mills; Paul Gissen; James E Davison
Journal:  J Inherit Metab Dis       Date:  2017-03-01       Impact factor: 4.982

Review 9.  Argininosuccinate lyase deficiency.

Authors:  Sandesh C S Nagamani; Ayelet Erez; Brendan Lee
Journal:  Genet Med       Date:  2012-01-05       Impact factor: 8.822

Review 10.  Novel biomarkers of abdominal aortic aneurysm disease: identifying gaps and dispelling misperceptions.

Authors:  Demetrios Moris; Eleftherios Mantonakis; Efthymios Avgerinos; Marinos Makris; Chris Bakoyiannis; Emmanuel Pikoulis; Sotirios Georgopoulos
Journal:  Biomed Res Int       Date:  2014-05-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.